Systematic Comparisons of Formulations of Linear Oligolysine Peptides with siRNA and Plasmid DNA

被引:27
作者
Kwok, Albert [1 ,3 ]
McCarthy, David [2 ]
Hart, Stephen L. [1 ]
Tagalakis, Aristides D. [1 ]
机构
[1] UCL, UCL Inst Child Hlth, Expt & Personalised Med Sect, 30 Guilford St, London WC1N 1EH, England
[2] UCL Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England
[3] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Box 289, Cambridge CB2 0QQ, England
基金
英国工程与自然科学研究理事会;
关键词
biophysical characteristics; DNA delivery; gene therapy; oligolysine peptide; RNA interference; siRNA delivery; GENE-TRANSFER COMPLEXES; POLY-L-LYSINE; IN-VITRO; POLYELECTROLYTE COMPLEXES; TARGETED NANOCOMPLEXES; MOLECULAR-WEIGHT; CELLULAR UPTAKE; HK PEPTIDES; DELIVERY; TRANSFECTION;
D O I
10.1111/cbdd.12709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of lysine peptide lengths on DNA and siRNA packaging and delivery were studied using four linear oligolysine peptides with 8 (K8), 16 (K16), 24 (K24) and 32 (K32) lysines. Oligolysine peptides with 16 lysines or longer were effective for stable monodisperse particle formation and optimal transfection efficiency with plasmid DNA (pDNA), but K8 formulations were less stable under anionic heparin challenge and consequently displayed poor transfection efficiency. However, here we show that the oligolysines were not able to package siRNA to form stable complexes, and consequently, siRNA transfection was unsuccessful. These results indicate that the physical structure and length of cationic peptides and their charge ratios are critical parameters for stable particle formation with pDNA and siRNA and that without packaging, delivery and transfection cannot be achieved.
引用
收藏
页码:747 / 763
页数:17
相关论文
共 63 条
[11]   Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].
Dash, PR ;
Read, ML ;
Barrett, LB ;
Wolfert, M ;
Seymour, LW .
GENE THERAPY, 1999, 6 (04) :643-650
[12]   The receptor-mediated endocytosis of nonspherical particles [J].
Decuzzi, P. ;
Ferrari, M. .
BIOPHYSICAL JOURNAL, 2008, 94 (10) :3790-3797
[13]   Mechanics of receptor-mediated endocytosis [J].
Gao, HJ ;
Shi, WD ;
Freund, LB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (27) :9469-9474
[14]   Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery [J].
Gary, Dana J. ;
Puri, Nitin ;
Won, You-Yeon .
JOURNAL OF CONTROLLED RELEASE, 2007, 121 (1-2) :64-73
[15]   DNA toroids: Stages in condensation [J].
Golan, R ;
Pietrasanta, LI ;
Hsieh, W ;
Hansma, HG .
BIOCHEMISTRY, 1999, 38 (42) :14069-14076
[16]   The effect of particle design on cellular internalization pathways [J].
Gratton, Stephanie E. A. ;
Ropp, Patricia A. ;
Pohlhaus, Patrick D. ;
Luft, J. Christopher ;
Madden, Victoria J. ;
Napier, Mary E. ;
DeSimone, Joseph M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (33) :11613-11618
[17]   Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro [J].
Grayson, Amy C. Richards ;
Doody, Anne M. ;
Putnam, David .
PHARMACEUTICAL RESEARCH, 2006, 23 (08) :1868-1876
[18]   Flexibility of RNA [J].
Hagerman, PJ .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1997, 26 :139-156
[19]   An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery [J].
Harbottle, RP ;
Cooper, RG ;
Hart, SL ;
Ladhoff, A ;
McKay, T ;
Knight, AM ;
Wagner, E ;
Miller, AD ;
Coutelle, C .
HUMAN GENE THERAPY, 1998, 9 (07) :1037-1047
[20]   Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector [J].
Hart, SL ;
Arancibia-Cárcamo, CV ;
Wolfert, MA ;
Mailhos, C ;
O'Reilly, NJ ;
Ali, RR ;
Coutelle, C ;
George, AJT ;
Harbottle, RP ;
Knight, AM ;
Larkin, DFP ;
Levinsky, RJ ;
Seymour, LW ;
Thrasher, AJ ;
Kinnon, C .
HUMAN GENE THERAPY, 1998, 9 (04) :575-585